The reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.25BTRY
306.75M · vs all stocks (USD)
Updated Oct 25, 2026
Revenue (TTM)
1.40BTRY
28.13M · vs all stocks (USD)
Updated Oct 25, 2026
Profit Margin
-74.77%
Updated Oct 25, 2026
Beta
0.3800x
vs all stocks
Updated Oct 25, 2026
52-Week Change
-79.88%
vs all stocks
Updated Oct 25, 2026
Market Capitalization
15.25BTRY
306.75M · vs all stocks (USD)
Updated Oct 25, 2026
Enterprise Value
22.76BTRY
457.68M · vs all stocks (USD)
Updated Oct 25, 2026
Price to Sales (TTM)
10.90x
Updated Oct 25, 2026
Price to Book (MRQ)
0.9560x
Updated Oct 25, 2026
Enterprise to Revenue
16.27x
Updated Oct 25, 2026
Enterprise to EBITDA
44.91x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.45×.Updated Oct 25, 2026
Gross Margin
19.73%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 23.39%.Updated Oct 25, 2026
Profit Margin
-74.77%
Updated Oct 25, 2026
Operating Margin
0.50%
Updated Oct 25, 2026
Return on Assets (TTM)
0.13%
Updated Oct 25, 2026
Return on Equity (TTM)
-5.02%
Updated Oct 25, 2026
Revenue (TTM)
1.40BTRY
28.13M · vs all stocks (USD)
Updated Oct 25, 2026
Revenue per Share (TTM)
0.4750TRYUpdated Oct 25, 2026
Quarterly Revenue Growth
-43.80%
Updated Oct 25, 2026
Gross Profit (TTM)
327.23MTRY
6.58M · vs all stocks (USD)
Updated Oct 25, 2026
EBITDA (TTM)
1.38BTRY
27.82M · vs all stocks (USD)
Updated Oct 25, 2026
Net Income (TTM)
-1.05BTRY
-21.04M · vs all stocks (USD)
Updated Oct 25, 2026
Quarterly Earnings Growth (YoY)
-25.80%
Updated Oct 25, 2026
Operating Cash Flow (TTM)
94.79MTRY
1.91M · vs all stocks (USD)
Updated Oct 25, 2026
Levered Free Cash Flow (TTM)
2.24BTRY
44.97M · vs all stocks (USD)
Updated Oct 25, 2026
Payout Ratio
0.00%
Updated Oct 25, 2026
Minority Interest (Equity)
22.58MTRYFY2025 · Dec 31, 2025
Revenue
1.38BTRYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.00BTRYFY2025 · Dec 31, 2025
Gross Profit
371.37MTRYFY2025 · Dec 31, 2025
Operating Income
74.29MTRY
1.49M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-1.34BTRYFY2025 · Dec 31, 2025
Income Tax Expense
278.93MTRYFY2025 · Dec 31, 2025
Net Income
-1.62BTRYFY2025 · Dec 31, 2025
EBIT
-726.11MTRYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.28BTRYFY2025 · Dec 31, 2025
Selling, General & Administrative
100.75MTRYFY2025 · Dec 31, 2025
Other Operating Expenses
41.22MTRYFY2025 · Dec 31, 2025
Non-operating Interest Income
50.13MTRYFY2025 · Dec 31, 2025
Non-operating Interest Expense
610.91MTRYFY2025 · Dec 31, 2025
EPS (Basic)
-0.5500TRYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.5500TRYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.94BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.94BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-1.62BTRYFY2025 · Dec 31, 2025
Minority Interests (P&L)
116.04KTRYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025
Operating Cash Flow
-2.61BTRYFY2025 · Dec 31, 2025
Free Cash Flow
-2.67BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
417.85MTRYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-1.62BTRYFY2025 · Dec 31, 2025
Other Non-cash Items
-1.55BTRYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
509.76MTRYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
39.17MTRYFY2025 · Dec 31, 2025
Capital Expenditures
-52.98MTRYFY2025 · Dec 31, 2025
Net Acquisitions
-316.01MTRYFY2025 · Dec 31, 2025
Purchase of Investments
-2.97MTRYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-371.96MTRYFY2025 · Dec 31, 2025
Long-term Debt Issuance
960.78MTRYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.23BTRYFY2025 · Dec 31, 2025
Other Financing Charges
599.47MTRYFY2025 · Dec 31, 2025
Net Financing Cash Flow
331.49MTRYFY2025 · Dec 31, 2025
Shares Outstanding
2.95BSharesUpdated Oct 25, 2026
Float Shares
73.78MSharesUpdated Oct 25, 2026
% Held by Insiders
85.45%
vs all stocks
Updated Oct 25, 2026
% Held by Institutions
18.21%
vs all stocks
Updated Oct 25, 2026
Total Cash (MRQ)
932.13MTRY
18.75M · vs all stocks (USD)
Updated Oct 25, 2026
Total Cash per Share (MRQ)
0.3170TRYUpdated Oct 25, 2026
Total Debt (MRQ)
8.15BTRY
164.00M · vs all stocks (USD)
Updated Oct 25, 2026
Total Debt to Equity (MRQ)
0.5023x
Updated Oct 25, 2026
Current Ratio (MRQ)
0.3540x
Updated Oct 25, 2026
Book Value per Share (MRQ)
5.41TRYUpdated Oct 25, 2026
Total Assets
20.95BTRY
421.34M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.53BTRYFY2025 · Dec 31, 2025
Total Liabilities
8.00BTRYFY2025 · Dec 31, 2025
Total Non-current Assets
19.42BTRYFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.49BTRYFY2025 · Dec 31, 2025
Total Current Liabilities
3.51BTRYFY2025 · Dec 31, 2025
Cash
238.82MTRYFY2025 · Dec 31, 2025
Cash Equivalents
179.03MTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
417.85MTRYFY2025 · Dec 31, 2025
Accounts Receivable
64.26MTRYFY2025 · Dec 31, 2025
Inventory
47.69MTRYFY2025 · Dec 31, 2025
Accounts Payable
498.08MTRYFY2025 · Dec 31, 2025
Short-term Debt
2.38BTRYFY2025 · Dec 31, 2025
Long-term Debt
2.06BTRYFY2025 · Dec 31, 2025
Common Stock (Book)
2.95BTRYFY2025 · Dec 31, 2025
Retained Earnings
8.49BTRYFY2025 · Dec 31, 2025
Total Shareholders' Equity
12.95BTRY
260.40M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
3.10MTRYFY2025 · Dec 31, 2025
52-Week Low
4.99TRYUpdated Oct 25, 2026
52-Week High
68.70TRYUpdated Oct 25, 2026
52-Week Change
-79.88%
vs all stocks
Updated Oct 25, 2026
Beta
0.3800x
vs all stocks
Updated Oct 25, 2026
50-Day MA
22.51TRYUpdated Oct 25, 2026
200-Day MA
41.07TRYUpdated Oct 25, 2026
Avg 10-Day Volume
48.80MSharesUpdated Oct 25, 2026
Avg 30-Day Volume
32.64MSharesUpdated Oct 25, 2026
Diluted EPS (TTM)
-0.3200TRYUpdated Oct 25, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.55: grey zoneSignificant
Altman Z-Score: 1.55
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Revenue is $28.13M, lower than 95% of all stocks globallySignificant